About this trial
Patients who have undergone arthrodesis of the first metatarsophalangeal joint due to hallux valgus or hallux rigidus are invited to participate in this study, which aims to investigate how the foot functions after this operation. Patients between 18 and 60 years of age at the time of surgery are eligible to participate. Questionnaires will be distributed to assess current sports function compared with function prior to surgery. Particular focus will be placed on function during cross-country skiing.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients who has underwent arthrodesis of the first metatarsofalangeal joint because of hallux rigidus or severe hallux valgus
Patients at age 18-60 at the date of surgery
At least one year follow-up, and maximum 5 years since surgery.
Disqualifiers
Non-Norwegian-speaking patients.
Impaired walking function.
Inability to cooperate.
Concomitant osteotomy of other metatarsals.
Trial population
Patients who underwent arthrodesis of the first metatarsophalangeal joint at Oslo University Hospital, Martina Hansens Hospital, or Sørlandet Hospital within the past 1-5 years will be evaluated for enrollment
Trial design
Cohort
Retrospective
Treatments tested in this trial
Arthrodesis
Procedure/SurgeryArhtrodesis of the first metatarsophalangeal joint
Treatment groups
Trial outcomes
Primary outcomes
Return to Cross country skiing
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Oslo University Hospital
Lead sponsor
Sorlandet Hospital HF
Collaborator
This trial is not recruiting at the moment. You can still explore other options: